Growth factor-based therapeutics using bone morphogenetic protein 2 (BMP-2) presents a promising strategy to reconstruct craniofacial bone defects such as mandible. However, clinical applications require supraphysiological BMP doses that often increase inappropriate adipogenesis, resulting in well-documented, cyst-like bone formation. Here we reported a novel complementary strategy to enhance osteogenesis and mandibular bone repair by using small-molecule phenamil that has been shown to be a strong activator of BMP signaling. Phenamil synergistically induced osteogenic differentiation of human bone marrow mesenchymal stem cells with BMP-2 while suppressing their adipogenic differentiation induced by BMP-2 in vitro. The observed pro-osteogenic and antiadipogenic activity of phenamil was mediated by expression of tribbles homolog 3 (Trb3) that enhanced BMP-smad signaling and inhibited expression of peroxisome proliferator-activated receptor gamma (PPARγ), a master regulator of adipogenesis. The synergistic effect of BMP-2+phenamil on bone regeneration was further confirmed in a critical-sized rat mandibular bone defect by implanting polymer scaffolds designed to slowly release the therapeutic molecules. These findings indicate a new complementary osteoinductive strategy to improve clinical efficacy and safety of current BMP-based therapeutics.
Get full access to this article
View all access options for this article.
References
1.
HadlocT.A., VacantiJ.P., and CheneyM.L.Tissue engineering in facial plastic and reconstructive surgery. Facial Plast Surg, 14, 197, 1998.
2.
GuerraM.F.M., CampoF.J.R., GíasL.N., and PérezJ.S.Rim versus sagittal mandibulectomy for the treatment of squamous cell carcinoma: two types of mandibular preservation. Head Neck, 25, 982, 2003.
3.
UrkenM.L., BuchbinderD., CostantinoP.D., SinhaU., OkayD., LawsonW., and BillerH.F.Oromandibular reconstruction using microvascular composite flaps: report of 210 cases. Arch Otolaryngol Head Neck Surg, 124, 46, 1998.
4.
SuhJ.D., SercarzJ.A., AbemayorE., CalcaterraT.C., RawnsleyJ.D., AlamD., and BlackwellK.E.Analysis of outcome and complications in 400 cases of microvascular head and neck reconstruction. Arch Otolaryngol Head Neck Surg, 130, 962, 2004.
5.
WaxM.K., and RosenthalE.Etiology of late free flap failures occurring after hospital discharge. Laryngoscope, 117, 1961, 2007.
6.
HidalgoD.A., and PusicA.L.Free-flap mandibular reconstruction: a 10-year follow-up study. Plast Reconstr Surg, 110, 438, 2002.
SchroederJ.E., and MosheiffR.Tissue engineering approaches for bone repair: concepts and evidence. Injury, 42, 609, 2011.
9.
SetoI., AsahinaI., OdaM., and EnomotoS.Reconstruction of the primate mandible with a combination graft of recombinant human bone morphogenetic protein-2 and bone marrow. J Oral Maxillofac Surg, 59, 53, 2001.
10.
ReddiA.H.Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol, 16, 247, 1998.
CarrageeE.J., HurwitzE.L., and WeinerB.K.A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J, 11, 471, 2001.
13.
JamesA.W., LaChaudG., ShenJ., AsatrianG., NguyenV., ZhangX., TingK., and SooC.A review of the clinical side effects of bone morphogenetic protein-2. Tissue Eng Part B Rev, 22, 284, 2016.
14.
KangQ., SongW.X., LuoQ., TangN., LuoJ., et al.A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev, 18, 545, 2009.
15.
KimI.S., LeeE.N., ChoT.H., SongY.M., HwangS.J., OhJ.H., ParkE.K., KooT.Y., and SeoY.K.Promising efficacy of Escherichia coli recombinant human bone morphogenetic protein-2 in collagen sponge for ectopic and orthotopic bone formation and comparison with mammalian cell recombinant human bone morphogenetic protein-2. Tissue Eng Part A, 17, 337, 2011.
16.
ZhangQ., HeQ.F., ZhangT.H., YuX.L., LiuQ., and DengF.L.Improvement in the delivery system of bone morphogenetic protein-2: a new approach to promote bone formation. Biomed Mater, 7, 045002, 2012.
17.
WuG., LiuY., IizukaT., and HunzikerE.B.The effect of as low mode of BMP-2 delivery on the inflammatory response provoked by bone-defect-filling polymeric scaffolds. Biomaterials, 31, 7485, 2010.
18.
JamesA.W., PangS., AskarinamA., CorselliM., ZaraJ.N., et al.Additive effects of sonic hedgehog and Nell-1 signaling in osteogenic versus adipogenic differentiation of human adipose-derived stromal cells. Stem Cells Dev, 21, 2170, 2012.
19.
MarcianoD.P., KuruvillaD.S., BoregowdaS.V., AsteianA., HughesT.S., et al.Pharmacological repression of PPARγ promotes osteogenesis. Nat Commun, 6, 74432015.
20.
FanJ., ImC.S., CuiZ.K., GuoM., BezouglaiaO., et al.Delivery of phenamil enhances BMP-2-induced osteogenic differentiation of adipose-derived stem cells and bone formation in calvarial defects. Tissue Eng Part A, 21, 2053, 2015.
21.
Fan.J., ImC.S., GuoM., CuiZ.K., FartashA., et al.Enhanced osteogenesis of adipose-derived stem cells by regulating bone morphogenetic protein signaling antagonists and agonists. Stem Cells Transl Med, 5, 539, 2016.
22.
LoK.W., AsheK.M., KanH.M., and LaurencinC.T.The role of small molecules in musculoskeletal regeneration. Regen Med, 7, 535, 2012.
23.
ParkK.W., WakiH., KimW.K., DaviesB.S., YoungS.G., et al.The small molecule phenamil induces osteoblast differentiation and mineralization. Mol Cell Biol, 29, 3905, 2009.
24.
LoK.W., KanH.M., and LaurencinC.T.Short-term administration of small molecule phenamil induced a protracted osteogenic effect on osteoblast-like MC3T3-E1 cells. J Tissue Eng Regen Med, 10, 518, 2013.
25.
KimJ.G., SonK.M., ParkH.C., ZhuT., KwonJ.H., and YangH.C.Stimulating effects of quercetin and phenamil on differentiation of human dental pulp cells. Eur J Oral Sci, 121, 559, 2013.
26.
TakahashiY., OhokaN., HayashiH., and SatoR.TRB3 suppresses adipocyte differentiation by negatively regulating PPARgamma transcriptional activity. J Lipid Res, 49, 880, 2008.
27.
BezyO., VernochetC., GestaS., FarmerS.R., and KahnC.R.TRB3 blocks adipocyte differentiation through the inhibition of C/EBPbeta transcriptional activity. Mol Cell Biol, 27, 6818, 2007.
28.
ChouY.F., DunnJ.C., and WuB.M.In vitro response of MC3T3-E1 pre-osteoblasts within three-dimensional apatite-coated PLGA scaffolds. J Biomed Mater Res B Appl Biomater, 75, 81, 2005.
ParkH., ChoiB., NguyenJ., FanJ., ShafiS., et al.Anionic carbohydrate-containing chitosan scaffolds for bone regeneration. Carbohydr Polym, 97, 587, 2013.
32.
LeeM., LiW., SiuR.K., WhangJ., ZhangX., et al.Biomimetic apatite-coated alginate/chitosan microparticles as osteogenic protein carriers. Biomaterials, 30, 6094, 2009.
33.
FanJ., ParkH., LeeM.K., BezouglaiaO., FartashA., KimJ., AghalooT., and LeeM.Adipose-derived stem cells and BMP-2 delivery in chitosan-based 3D constructs to enhance bone regeneration in a rat mandibular defect model. Tissue Eng Part A, 20, 2169, 2014.
34.
FerrettiC., and RipamontiU.Human segmental mandibular defects treated with naturally derived bone morphogenetic proteins. J Craniofac Surg, 13, 434, 2002.
35.
MckayW.F., PeckhamS.M., and BaduraJ.M.A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® Bone Graft). Int Orthop, 2, 729, 2007.
36.
ArosarenaO., and CollinsW.Comparison of BMP-2 and −4 for rat mandibular bone regeneration at various doses. Orthod Craniofac Res, 8, 267, 2005.
37.
WenB., KarlM., PendrysD., ShaferD., FreilichM., and KuhnL.An evaluation of BMP-2 delivery from scaffolds with miniaturized dental implants in a novel rat mandible model. J Biomed Mater Res B Appl Biomater, 97, 315, 2001.
38.
ZaraJ.N., SiuR.K., ZhangX., ShenJ., NgoR., et al.High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A, 17, 1389, 2011.
39.
AstudilloP., RíosS., PastenesL., PinoA.M., and RodríguezJ.P.Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) characterizes by impaired leptin action. J Cell Biochem, 103, 1054, 2008.
40.
BorstingE., PatelS.V., DeclèvesA.E., LeeS.J., RahmanQ.M., et al.Tribbles homolog 3 attenuates mammalian target of rapamycin complex-2 signaling and inflammation in the diabetic kidney. J Am Soc Nephrol, 25, 2067, 2014.
41.
BoerckelJ.D., KolambkarY.M., DupontK.M., UhrigB.A., PhelpsE.A., et al.Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials, 32, 5241, 2011.
42.
FanJ., ParkH., TanS., and LeeM.Enhanced osteogenesis of adipose derived stem cells with Noggin suppression and delivery of BMP-2. PLoS One, 8, e72474, 2013.
43.
HuJ., HouY., ParkH., and LeeM.Beta-tricalcium phosphate particles as a controlled release carrier of osteogenic proteins for bone tissue engineering. J Biomed Mater Res A, 100, 1680, 2012.
44.
ChouY.F., HuangW., DunnJ.C., MillerT.A., and WuB.M.The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression. Biomaterials, 26, 285, 2015.
45.
PascaudP., ErrassifiF., BrouilletF., SardaS., BarrougA., et al.Adsorption on apatitic calcium phosphates for drug delivery: interaction with bispho-sphonate molecules. J Mater Sci Mater Med, 25, 2373, 2014.
46.
HusseinK.A., ZakharyI.E., ElawadyA.R., EmamH.A., SharawyM., et al.Difference in soft tissue response between immediate and delayed delivery suggests a new mechanism for recombinant human bone morphogenetic protein 2 action in large segmental bone defects. Tissue Eng Part A, 18, 665, 2012.
47.
JégouxF, GoyenvalleE, CognetR, MalardO., MoreauF., et al.Mandibular segmental defect regenerated with macroporous biphasic calcium phosphate, collagen membrane, and bone marrow graft in dogs. Arch Otolaryngol Head Neck Surg, 136, 971, 2010.
48.
SchliephakeH., WeichH.A., DullinC., GruberR., and FrahseS.Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid—an experimental study in rats. Biomaterials, 29, 103, 2008.
49.
SidellD.R., AghalooT., TetradisS., LeeM., BezouglaiaO., DeCondeA., and St JohnM.Composite mandibulectomy: a novel animal model. Otolaryngol Head Neck Surg, 146, 932, 2012.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
